Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pharmather Hldgs Ltd (PHRRF)

Pharmather Hldgs Ltd (PHRRF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PHRRF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1419 +59.90%
on 04/08/21
0.2700 -15.96%
on 03/19/21
+0.0169 (+8.05%)
since 03/16/21
3-Month
0.1419 +59.90%
on 04/08/21
1.3900 -83.68%
on 01/19/21
-0.0981 (-30.18%)
since 01/15/21

Most Recent Stories

More News
PharmaTher Provides Update on Psychedelic Product Programs

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (CSE: PHRM) (OTCQB: PHRRF), a specialty psychedelic pharmaceutical company, is pleased to provide an update on its psychedelic product programs...

RVVTF : 0.3440 (-1.71%)
PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)
Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027

, /PRNewswire/ -- The psychedelics industry may appear to have suddenly emerged as one of the hottest corners of the stock market, but researchers have been working for decades to show the efficacy of...

MINE : 0.0039 (unch)
RVV.CN : 0.430 (-2.27%)
RVVTF : 0.3440 (-1.71%)
PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)
PULL.CN : 0.395 (+1.28%)
PRXTF : 0.3120 (+2.16%)
PSYG.CN : 0.310 (-10.14%)
HAVN.CN : 0.720 (-1.37%)
HAVLF : 0.5691 (-0.91%)
Newscope Announces Name Change to PharmaTher Holdings Ltd.

Newscope Capital Corporation (the "Company") (CSE: PHRM) (OTCQB: PHRRF) is pleased to announce that, further to the news release dated April 8, 2021, its common shares will commence trading through the...

PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)
Newscope Announces Name Change

Newscope Capital Corporation (the "Company") (CSE: PHRM) (OTCQB: PHRRF) is pleased to announce that it has filed an alteration notice with BC Registry Services changing the name of the Company to PharmaTher...

PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)
Newscope Capital Provides Dial-In Information for Special Meeting

Newscope Capital Corporation (the "Company") (CSE: PHRM) (OTCQB: PHRRF) would like to provide the following dial-in information for the Company's upcoming Special Meeting (the "Meeting") scheduled to be...

PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)
PharmaTher Advancing Research for Novel Microneedle Delivery of Ketamine

PharmaTher Advancing Research for Novel Microneedle Delivery of Ketamine

PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)
World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific and Clinical Advisor

Newscope Capital Corporation (the "Company" or "Newscope") (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. ("PharmaTher"), is a specialty life sciences company focused...

PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)
Global Behavioral Health Market Where Psychedelics Have Shown Tremendous Potential Could Hit $240 Billion By 2026

, /PRNewswire/ -- Many people and investors may be confused, thinking that the Psychedelics market is part of the cannabis market. It is not a way to get higher 'highs' in the legal cannabis market…...

MCUR.CN : 0.380 (-7.32%)
CLXPF : 1.4000 (-3.45%)
MCURF : 0.3204 (-0.53%)
CMPS : 34.35 (+0.94%)
FTRP.CN : 6.020 (+2.03%)
FTRPF : 4.8218 (+3.37%)
RVV.CN : 0.430 (-2.27%)
RVVTF : 0.3440 (-1.71%)
PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)
Ketamine Could Potentially Increase Life Expectancy for Lou Gehrig’s Disease Patients

Psychedelics, like ketamine could be a game-changer for the medical community. In addition to psilocybin, ...

MMEDF : 2.4300 (-0.82%)
CMPS : 34.35 (+0.94%)
MYCOF : 0.2749 (+1.81%)
PSYC.CN : 0.250 (-3.85%)
PSYCF : 0.2006 (-2.86%)
PHRRF : 0.2269 (+8.05%)
MYCO.CN : 0.400 (-6.98%)
PHRM.CN : 0.280 (+5.66%)
PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig's Disease

Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. ("PharmaTher"), is a specialty life sciences company focused on the research and development...

PHRM.CN : 0.280 (+5.66%)
PHRRF : 0.2269 (+8.05%)

Key Turning Points

3rd Resistance Point 0.2654
2nd Resistance Point 0.2531
1st Resistance Point 0.2400
Last Price 0.2269
1st Support Level 0.2146
2nd Support Level 0.2023
3rd Support Level 0.1892

See More

52-Week High 1.3900
Fibonacci 61.8% 0.8972
Fibonacci 50% 0.7450
Fibonacci 38.2% 0.5928
Last Price 0.2269
52-Week Low 0.1000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar